To further investigate the potential role of LTF as a biomarker for AD, we examined LTF expression in both systemic and central compartments in the context of the AD diagnostic continuum in the largest dataset reported to date (N= 1,367). The gene discussed is LTF; the disease is Alzheimer disease.